Canakinumab for Treatment of Adult-Onset Still's Disease to Achieve Reduction of Arthritic Manifestation (CONSIDER): phase II, randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial

DSpace Repository

Canakinumab for Treatment of Adult-Onset Still's Disease to Achieve Reduction of Arthritic Manifestation (CONSIDER): phase II, randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial

Author: Kedor, Claudia; Listing, Joachim; Zernicke, Jan; Weiss, Anja; Behrens, Frank; Blank, Norbert; Henes, Joerg Christoph; Kekow, Joern; Rubbert-Roth, Andrea; Schulze-Koops, Hendrik; Seipelt, Eva; Specker, Christof; Feist, Eugen
Tübinger Autor(en):
Henes, Jörg Christoph
Published in: Annals of The Rheumatic Diseases (2020), Bd. 79, H. 8, S. 1090-1097
Verlagsangabe: Bmj Publishing Group
Language: English
Full text: http://dx.doi.org/10.1136/annrheumdis-2020-217155
ISSN: 1468-2060
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)